您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

matriks/Shikari® (S-ATP) Anti-Pembrolizumab ELISA w/confirmation/PEM-QNS-KEY

Enzyme immunoassay for the quantitative determination (screening) of antibodies to Pembrolizumab (Keytruda®) in serum and plasma with confirmation.

This kit has been especially developed for the quantitative determination of antibodies to pembrolizumab in serum and plasma samples.

Pembrolizumab (Keytruda®) was associated to the development of anti-Pembrolizumab antibodies, even some were reported to be neutralizing, in various percentages of patients during therapy with the drug Keytruda®. This might lead to severe complications. This kit can be efficiently used for monitoring anti-Pembrolizumab antibodies during therapy and offers the clinician a tool for decision on possible preventive measures such as possible addition of immunosuppressive drug to reduce anti-Pembrolizumab antibodies. 

All SHIKARI® ELISA kits are suitable for biosimilar work.

All SHIKARI® ELISA kits are produced under ISO 13485 quality system and have CE IVD mark.

For technical inquiry, please contact techsupport@matriksbiotek.com

 

 

 

新闻动态
行业前沿
技术文章
最新产品